Reshape Raises $20M in Funding to Expand Operations and Automate R&D
Reshape Raises $20M in Series A Funding
Reshape's Series A Funding
Key Highlights:
- Series A Funding: Reshape, an AI and robotics-powered imaging and analysis platform provider, raised $20 million in Series A funding.
- Investors: Funding round led by Astanor Ventures, R7, ACME, Y Combinator, Nicholas Francis (Unity Co-Founder), and 21stBio.
- Expansion Plans: Funds will be used to expand Reshape's operations in the US and further automate R&D processes for agricultural, industrial, and biotech organizations.
Reshape's Target Market
- Biological Research Labs: Research labs in the agricultural, industrial, and biotech sectors looking to automate visual experiments and improve research efficiency.
- Leading Organizations: Reshape's technology is already used by prominent organizations such as Syngenta, University of Oxford, and Novozymes.
- Time and Cost Savings: Reshape's solution helps research labs save significant time and resources by minimizing errors and automating manual research processes.
What Reshape Needs to Buy
- US Expansion Support: Services and resources to support Reshape's expansion into the US market, including establishing a local presence and building partnerships.
- Research and Development Collaboration: Collaborations with agricultural, industrial, and biotech organizations for further development and customization of Reshape's imaging and analysis platform.
- Marketing and Sales Expertise: Assistance from marketing and sales professionals to effectively promote Reshape's technology and attract new customers.